These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 957533)

  • 1. Rauwolfia derivatives and breast cancer.
    Lilienfeld AM; Chang L; Thomas DB; Levin ML
    Johns Hopkins Med J; 1976 Aug; 139(2):41-50. PubMed ID: 957533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion bias and the false relationship of reserpine and breast cancer.
    Horwitz RI; Feinstein AR
    Arch Intern Med; 1985 Oct; 145(10):1873-5. PubMed ID: 4037948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserpine and breast cancer in a retirement community.
    Mack TM; Henderson BE; Gerkins VR; Arthur M; Baptista J; Pike MC
    N Engl J Med; 1975 Jun; 292(26):1366-71. PubMed ID: 1138164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program.
    Williams RR; Feinleib M; Connor RJ; Stegens NL
    J Natl Cancer Inst; 1978 Aug; 61(2):327-35. PubMed ID: 277719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rauwolfia use and breast cancer: a case-control study.
    Stanford JL; Martin EJ; Brinton LA; Hoover RN
    J Natl Cancer Inst; 1986 May; 76(5):817-22. PubMed ID: 3457968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women.
    Ross RK; Paganini-Hill A; Krailo MD; Gerkins VR; Henderson BE; Pike MC
    Cancer Res; 1984 Jul; 44(7):3106-8. PubMed ID: 6722826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for in situ breast cancer.
    Longnecker MP; Bernstein L; Paganini-Hill A; Enger SM; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):961-5. PubMed ID: 8959317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants.
    Tamim H; Boivin JF; Hanley J; Stang M; Collet JP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):689-97. PubMed ID: 16555372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl)].
    Clavel F; Lê M; Laplanche A
    Bull Cancer; 1981; 68(5):449-55. PubMed ID: 7332791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer.
    Helzlsouer KJ; Alberg AJ; Huang HY; Hoffman SC; Strickland PT; Brock JW; Burse VW; Needham LL; Bell DA; Lavigne JA; Yager JD; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):525-32. PubMed ID: 10385143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee consumption and the risk of breast cancer.
    Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rauwolfia preparations and breast cancer].
    Ugeskr Laeger; 1974 Nov; 136(45):2536. PubMed ID: 4425388
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of breast cancer].
    Margreiter R
    Wien Med Wochenschr; 1978 Dec; 128(24):747-52. PubMed ID: 369153
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is there a basis for the suggested significance of rauwolfia preparations in the development of breast cancer?].
    Tikhonova NA; Lazarev NI; Samoĭlenko LA
    Klin Med (Mosk); 1979 May; 57(5):52-6. PubMed ID: 480869
    [No Abstract]   [Full Text] [Related]  

  • 17. Reserpine and breast cancer in women in germany.
    Kewitz H; Jesdinsky HJ; Schröter PM; Lindtner E
    Eur J Clin Pharmacol; 1977 Jan; 11(2):79-83. PubMed ID: 837970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Nov; 2(7892):1315-7. PubMed ID: 4139545
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Oct; 2(7886):966-7. PubMed ID: 4138380
    [No Abstract]   [Full Text] [Related]  

  • 20. Matched-pairs study of reserpine use and breast cancer.
    Laska EM; Siegel C; Meisner M; Fischer S; Wanderling J
    Lancet; 1975 Aug; 2(7929):296-300. PubMed ID: 50508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.